Future Specialty Care Portfolio Strategy Lead – US Specialty Care (12 Month Secondment)

Pfizer•New York City, NY

44d

About The Position

US lead for the development of a forward-looking Specialty Care portfolio strategy bridging current assets with future pipeline opportunities to strengthen long-term competitiveness. Collaborate across therapeutic areas, Medical, R&D, Global Marketing, CSI, and BD&L to provide US market inputs, shape strategic direction, inform future investment decisions, and create organizational readiness. US lead to establish a comprehensive Respiratory strategy, preparing for trispecifics and broader Specialty Care pipeline launches.

Requirements

12+ years in strategy, new product planning, portfolio management, BD&L collaboration, or related roles in Specialty Care TAs or respiratory.
Strong experience influencing strategic decisions across cross-functional teams, including R&D, BD&L, Marketing, Medical, and Finance.
Proven ability to lead strategic planning, portfolio shaping, and valuation of business opportunities.
Exceptional communication, executive engagement, and strategic storytelling skills.
Strong strategic thinking, ability to navigate ambiguity, and comfort operating at the enterprise level

Responsibilities

Develop and articulate the long-term Specialty Care portfolio vision for the US, ensuring alignment between today’s portfolio and future pipeline assets.
Identify strategic gaps, unmet needs, and opportunities to strengthen the portfolio’s competitive positioning.
US lead for portfolio scenario planning, future readiness assessments, and strategic prioritization for investment and resource alignment.
Deliver a US market implementation roadmap for 2026-2028 with interdependencies and clear execution plans for each stakeholder, including actions by cross-functional owners, milestones, and deliverable deadlines to address readiness gaps
Outline and begin pre-launch US market engagement activities to shape and validate the market opportunity with key stakeholders, such thought leader engagement, conference attendance, and conducting product theaters or ad boards
Collaborate closely with Therapeutic Area Leads and Medical to translate disease area trends, evolving science, and unmet needs into future strategic priorities.
Work with CSI, Medical, and Global Marketing to shape positioning, value propositions, and market readiness for early and late-stage pipeline assets.
Engage with R&D and Medical to align scientific direction with strategic priorities, ensuring future assets address key growth opportunities.
Partner with CSI/GCA to integrate market trends, environmental dynamics, competitive intelligence, and customer insight into future portfolio planning.
Partner with BD&L to inform external opportunity scanning, ensuring alignment with portfolio strategy and identified unmet needs.
Define strategic criteria and therapeutic priorities to guide BD&L in asset identification and evaluation.
Support scientific and commercial assessments of external opportunities, including valuations and strategic fit analysis.
Contribute to internal alignment and recommendation processes to secure support for BD&L-informed strategic directions.
Lead the development of a comprehensive US Respiratory strategy, including preparation plans for trispecific launch and future R&D portfolio launches.
Assess emerging science, competitive dynamics, and evolving market landscapes in respiratory.
Define long-term Respiratory positioning, launch pathways, and cross-functional readiness milestones and owners.
Synthesize complex insights into clear, strategic recommendations for senior leadership, including the President of US Specialty Care.
Lead executive-level discussions on portfolio prioritization, sequencing, investment, and external commercial opportunity alignment.
Drive cross-functional alignment to ensure cohesive execution of the Specialty Care future strategy.